{"nct_id":"NCT03761056","title":"Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2019-01-29","start_date_type":"ACTUAL","primary_completion_date":"2023-10-12","primary_completion_date_type":"ACTUAL","completion_date":"2023-10-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GILD"]}